Macrophage-targeting nano-formulated bicalutamide alleviates colitis by inducing MAP3K1-mediated degradation of NLRP3Suqin Zhong, Xueqing Yao, Yinyin Yang et al.|Journal of Controlled Release|2025Cited by 3